HIGHLIGHTS
- who: S. Larrat et al. from the Laboratoire Virologie, Institut Biologie et Pathologie, Grenoble-Alpes, Grenoble, France have published the paper: Epidemiology and Infection Original Paper, in the Journal: (JOURNAL)
- what: The aim of this study was to investigate the epidemiological characteristics and distribution of HCV genotypes in treatment-naive patients with a METAVIR fibrosis stage between F0 and F2, in France .
SUMMARY
A combination of sofosbuvir and anti-NS5A treatment given to genotype 1-infected patients was associated with SVR rates from 92% to 99% in real life studies. In . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.